K-562-GFP Cells
1 104,00 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | K-562-GFP cells are a genetically modified variant of the human chronic myelogenous leukemia (CML) cell line K-562, originally derived from the peripheral blood of an adult patient in blast crisis. The parental K-562 line is characterized by the presence of the Philadelphia chromosome, resulting in the BCR-ABL fusion protein with constitutive tyrosine kinase activity, which drives uncontrolled proliferation and survival. K-562 cells exhibit erythroleukemia features and can be induced to undergo differentiation along erythroid, megakaryocytic, or monocytic lineages under specific experimental conditions, making them a versatile model for studying hematopoietic differentiation and leukemia biology. The introduction of green fluorescent protein (GFP) into K-562 cells enables real-time visualization and tracking of leukemic cell behavior in vitro and in vivo. K-562-GFP cells are widely used in assays involving cell proliferation, migration, and drug response, as well as in co-culture systems to study interactions with stromal or immune cells. The fluorescent labeling facilitates applications such as flow cytometry, live-cell imaging, and high-throughput screening. |
|---|---|
| Organisme | Human |
| Tissu | Pleural effusion |
| Maladie | Chronic myeloid leukemia |
Caractéristiques
| Âge | 53 years |
|---|---|
| Genre | Female |
| Origine ethnique | Caucasian |
| Morphologie | Lymphoblast-like |
| Type de cellule | Lymphoblast |
| Propriétés de croissance | Suspension |
Données réglementaires
| Référence | K562-GFP (Cytion catalog number 305948) |
|---|---|
| Niveau de biosécurité | 1 |
| NCBI_Numéro d'identification fiscale | 9606 |
| Cellosaurus - Numéro d'enregistrement | CVCL_1G55 |
Données biomoléculaires
| Expression des protéines | GFP |
|---|---|
| Profil mutationnel | Mutation: p.Gln136fs*13, Homozygous |
Manipulation
| Milieu de culture | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suppléments | Supplement the medium with 10% FBS |
| Réactif de dissociation | None |
| Repiquage | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth. |
| Densité de semis | 0.3 to 1 x 106 cells/ml |
| Renouvellement des fluides | 2 to 3 times per week |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
Certificat d'analyse (CoA)
| Numéro de lot | Type de certificat | Date | Numéro de catalogue |
|---|---|---|---|
| 305948-120326 | Certificat d'analyse | 13. Apr. 2026 | 305948 |